| Literature DB >> 33984606 |
Masashi Mizumoto1, Hiroshi Fuji2, Mitsuru Miyachi3, Toshinori Soejima4, Tetsuya Yamamoto5, Norihiro Aibe6, Yusuke Demizu4, Hiromitsu Iwata7, Takayuki Hashimoto8, Atsushi Motegi9, Atsufumi Kawamura10, Keita Terashima11, Takashi Fukushima12, Tomohei Nakao13, Akinori Takada14, Minako Sumi15, Junjiro Oshima16, Kensuke Moriwaki17, Miwako Nozaki18, Yuji Ishida19, Yoshiyuki Kosaka20, Keisuke Ae21, Ako Hosono22, Hideyuki Harada23, Etsuyo Ogo24, Tetsuo Akimoto9, Takashi Saito1, Hiroko Fukushima25, Ryoko Suzuki25, Mitsuru Takahashi26, Takayuki Matsuo27, Akira Matsumura28, Hidekazu Masaki29, Hajime Hosoi3, Naoyuki Shigematsu30, Hideyuki Sakurai31.
Abstract
Children and adolescents and young adults (AYAs) with cancer are often treated with a multidisciplinary approach. This includes use of radiotherapy, which is important for local control, but may also cause adverse events in the long term, including second cancer. The risks for limited growth and development, endocrine dysfunction, reduced fertility and second cancer in children and AYAs are reduced by proton beam therapy (PBT), which has a dose distribution that decreases irradiation of normal organs while still targeting the tumor. To define the outcomes and characteristics of PBT in cancer treatment in pediatric and AYA patients, this document was developed by the Japanese Society for Radiation Oncology (JASTRO) and the Japanese Society of Pediatric Hematology/Oncology (JSPHO).Entities:
Keywords: AYA; Children; Guideline; Pediatric; Proton beam therapy
Year: 2021 PMID： 33984606 DOI： 10.1016/j.ctrv.2021.102209
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111